The Changes of Blood Glucose Control and Lipid Profiles after Short-Term Smoking Cessation in Healthy Males
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective Our aim was to evaluate the changes in blood glucose control and lipid profiles after 2-months of smoking cessation in healthy males. Methods Smoking abstinence was evaluated through self-report and urine cotinine levels. 12 individuals who succeeded in quitting smoking were analyzed. Fasting values of glucose and insulin were used to estimate the β-cell activity and insulin resistance was evaluated using the Homeostasis Model Assessment (HOMA) and Quantitative Insulin Sensitivity Check Index (QUICKI). Results The data showed that the subjects had a significant increase in weight, body mass index and fasting plasma glucose levels after smoking cessation. The HOMA-Insulin Resistance and the HOMA β-cell function increased significantly (p=0.005, p=0.047 respectively). The QUICKI showed a significant decrease (p=0.005). In addition, the low-density lipoprotein cholesterol levels decreased significantly (p=0.028); however, changes in the high-density lipoprotein cholesterol, the triglyceride and total cholesterol levels were not significant (p=0.284, p=0.445 respectively). Conclusion During the initial stage of smoking abstinence, insulin resistance increased and insulin sensitivity decreased due to elevated body weight and fat composition. Therefore, it is important to educate individuals that stop smoking about the necessity of weight control during smoking cessation programs.
Abstract
Objective Our aim was to evaluate the changes in blood glucose control and lipid profiles after 2-months of smoking cessation in healthy males. Methods Smoking abstinence was evaluated through self-report and urine cotinine levels. 12 individuals who succeeded in quitting smoking were analyzed. Fasting values of glucose and insulin were used to estimate the β-cell activity and insulin resistance was evaluated using the Homeostasis Model Assessment (HOMA) and Quantitative Insulin Sensitivity Check Index (QUICKI). Results The data showed that the subjects had a significant increase in weight, body mass index and fasting plasma glucose levels after smoking cessation. The HOMA-Insulin Resistance and the HOMA β-cell function increased significantly (p=0.005, p=0.047 respectively). The QUICKI showed a significant decrease (p=0.005). In addition, the low-density lipoprotein cholesterol levels decreased significantly (p=0.028); however, changes in the high-density lipoprotein cholesterol, the triglyceride and total cholesterol levels were not significant (p=0.284, p=0.445 respectively). Conclusion During the initial stage of smoking abstinence, insulin resistance increased and insulin sensitivity decreased due to elevated body weight and fat composition. Therefore, it is important to educate individuals that stop smoking about the necessity of weight control during smoking cessation programs.
참고문헌 (45)
- Craig WY, "Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data", BMJ, 298, pp.784~788 (1989)
- Celemajer DS, "Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults", Circulation, 88, pp.2149~2155 (1993)
- Kannel WB, "Update on the role of cigarette smoking in coronary artery disease", Am Heart J, 101, pp.319~328 (1981)
- Kannel WB, "Cigarettes, coronary occlusions, and myocardial infarction", JAMA, 246, pp.871~872 (1981)
- Lakier JB, "Smoking and cardiovascular disease", Am J Med, 93, pp.8S~12S (1992)
- Yusuf S, "Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study", Lancet, 364, pp.937~952 (2004)
- Rosenberg L, "Decline in the risk of myocardial infarction among women who stop smoking", N Engl J Med, 322, pp.213~217 (1990)
- Sato I, "Beneficial effect of stopping smoking on future cardiac events in male smokers with previous myocardial infarction", Jpn Circ J, 56, pp.217~222 (1992)
- Kong C, "Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes", Atherosclerosis, 156, pp.373~378 (2001)
- Facchini FS, "Insulin resistance and cigarette smoking", Lancet, 39, pp.1128~1130 (1992)
- Targher G, "Cigarette smoking and insulin resistance in patients with noninsulin-dependent diabetes mellitus", J Clin Endocrinol Metab, 82, pp.3619~3624 (1997)
- Elkeles RS, "Effects of smoking on oral fat tolerance and high density lipoprotein cholesterol", Clin Sci, 65, pp.669~672 (1983)
- Richmond W, "Impaired intravascular lipolysis with changes in concentrations of high density lipoprotein subclasses in young smokers", Br Med J, 295, pp.246~247 (1987)
- Austin MA, "Low-density lipoprotein subclass patterns and risk of myocardial infarction", JAMA, 260, pp.1917~1921 (1998)
- Krauss RM, "The tangled web of coronary risk factors", Am J Med, 90, pp.36S~41S (1991)
- Maeda K,, "The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis", Prev Med, 37, pp.283~290 (2003)
- Heatherton TF, "The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire", Br J Addict, 86, pp.1119~1127 (1991)
- Sandberg H, "The effect of smoking on serum somatotropin, immunoreactive insulin and blood glucose levels of young adult males", J Pharmacol Exp Ther, 184, pp.787~791 (1973)
- Janzon L, "Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men", Diabetologia, 25, pp.86~88 (1983)
- Attvall S, "Smoking induces insulin resistan--potential link with the insulin resistance syndrome", J Intern Med, 233, pp.327~332 (1993)
- Sargeant LA, "Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer", Int J Epidemiol, 30, pp.547~554 (2001)
- Niedermaier ON, "Influence of cigarette smoking on human autonomic function", Circulation, 88, pp.562~571 (1993)
- Lucini D, "A controlled study of the autonomic changes produced by habitual cigarette smoking in healthy subjects", Cardiovasc Res, 31, pp.633~639 (1996)
- Eliasson B, "Cigarette smoking and diabetes", Prog Cardiovasc Dis, 45, pp.405~413 (2003)
- Eliasson B,, "Smoking cessation improves insulin sensitivity in healthy middle-aged men", Eur J Clin Invest, 27, pp.450~456 (1997)
- Mikhailidis DP, "Smoking, diabetes and hyperlipidaemia", J R Soc Health, 118, pp.91~93 (1998)
- Daniel M, "Association between smoking, insulin resistance and beta cell function in a North-western First Nation", Diabet Med, 21, pp.188~193 (2004)
- Henkin L, "Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study", Ann Epidemiol, 9, pp.290~296 (1999)
- Halfon ST, "Smoking status and lipid levels in adults of different ethnic origins: the Jerusalem Lipid Research Clinic Program", Int J Epidemiol, 13, pp.177~183 (1984)
- Freedman DS, "Cigarette smoking initiation and longitudinal changes in serum lipids and lipoproteins in early adulthood: the Bogalusa Heart Study", Am J Epidemiol, 124, pp.207~219 (1986)
- Kuzuya M, "Effect of smoking habit on age-related changes in serum lipids: a cross-sectional and longitudinal analysis in a large Japanese cohort", Atherosclerosis, 185, pp.183~190 (2006)
- Hughes K, "Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore", Atherosclerosis, 137, pp.253~258 (1998)
- Freeman DJ, "Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution", Eur J Clin Invest, 23, pp.630~640 (1993)
- Zaratin AC, "Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport", Metabolism, 53, pp.858~862 (2004)
- Dullaart RP, "Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men", Arterioscler Thromb, 14, pp.1581~1585 (1994)
- Eliasson B, "The insulin resistance syndrome and postprandial lipid intolerance in smokers", Atherosclerosis, 129, pp.79~88 (1997)
- Gerace TA, "Smoking cessation and cha-nge in diastolic blood pressure, body weight, and plasma lipids. MRFIT Research Group", Prev Med, 20, pp.602~620 (1991)
- Sasaki A, "Smoking cessation increases the resistance of low-density lipoprotein to oxidation", Atherosclerosis, 130, pp.109~111 (1997)
- Moffatt RJ, "Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C", Prev Med, 38, pp.637~641 (2004)
- Freeman DJ, "Smoking and plasma lipoprotein metabolism", Clin Sci, 89, pp.333~342 (1995)
- Reaven GM, "Pathophysiology of insulin resistance in human disease", Physiol Rev, 75, pp.473~486 (1995)
- Reaven GM, "Banting Iecture 1988. Role of insulin resistance in human disease", Diabetes, 37, pp.1595~1607 (1988)
- Delfino RJ, "Temporal analysis of the relationship of smoking behavior and urges to mood states in men versus women", Nicotine Tob Res, 3, pp.235~248 (2001)
- Fallon JH, "Gender: a major determinant of brain response to nicotine", Int J Neuropsychopharmacol, 8, pp.1726~ (2005)
- 김용구, "Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation", NEUROSCIENCE LETTERS, 423, pp.53~57
